Waters Co. (NYSE:WAT) Short Interest Up 8.4% in July

Share on StockTwits

Waters Co. (NYSE:WAT) was the recipient of a significant growth in short interest during the month of July. As of July 31st, there was short interest totalling 4,186,200 shares, a growth of 8.4% from the June 30th total of 3,862,000 shares. Currently, 6.2% of the company’s shares are sold short. Based on an average daily trading volume, of 595,600 shares, the days-to-cover ratio is presently 7.0 days.

A number of research analysts have recently issued reports on WAT shares. Robert W. Baird reduced their price objective on Waters from $211.00 to $209.00 and set a “neutral” rating on the stock in a research note on Wednesday, April 24th. Zacks Investment Research raised Waters from a “sell” rating to a “hold” rating and set a $217.00 price objective on the stock in a research note on Wednesday, May 22nd. Cleveland Research cut Waters from a “neutral” rating to an “underperform” rating in a research note on Wednesday, June 12th. UBS Group reduced their price objective on Waters from $248.00 to $230.00 and set a “neutral” rating on the stock in a research note on Wednesday, April 24th. Finally, ValuEngine cut Waters from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. Five investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and one has given a buy rating to the company. The stock currently has an average rating of “Hold” and an average price target of $210.54.

Several institutional investors have recently bought and sold shares of WAT. Cambridge Investment Research Advisors Inc. increased its stake in shares of Waters by 7.4% during the second quarter. Cambridge Investment Research Advisors Inc. now owns 1,763 shares of the medical instruments supplier’s stock valued at $379,000 after purchasing an additional 121 shares in the last quarter. Zacks Investment Management increased its stake in shares of Waters by 37.4% during the second quarter. Zacks Investment Management now owns 25,925 shares of the medical instruments supplier’s stock valued at $5,580,000 after purchasing an additional 7,062 shares in the last quarter. Nuveen Asset Management LLC increased its stake in shares of Waters by 446.3% during the second quarter. Nuveen Asset Management LLC now owns 227,575 shares of the medical instruments supplier’s stock valued at $48,984,000 after purchasing an additional 185,918 shares in the last quarter. Victory Capital Management Inc. increased its stake in shares of Waters by 14.3% during the second quarter. Victory Capital Management Inc. now owns 16,210 shares of the medical instruments supplier’s stock valued at $3,489,000 after purchasing an additional 2,027 shares in the last quarter. Finally, UBS Asset Management Americas Inc. increased its stake in shares of Waters by 2.3% during the second quarter. UBS Asset Management Americas Inc. now owns 472,001 shares of the medical instruments supplier’s stock valued at $101,593,000 after purchasing an additional 10,728 shares in the last quarter. Institutional investors own 96.08% of the company’s stock.

Waters stock opened at $202.26 on Friday. The company has a current ratio of 2.65, a quick ratio of 2.07 and a debt-to-equity ratio of 2.00. The firm has a 50-day moving average of $214.38 and a 200-day moving average of $224.06. The firm has a market cap of $13.35 billion, a P/E ratio of 24.40, a P/E/G ratio of 2.30 and a beta of 1.07. Waters has a 1-year low of $167.93 and a 1-year high of $255.21.

Waters (NYSE:WAT) last posted its earnings results on Tuesday, July 30th. The medical instruments supplier reported $2.14 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.11 by $0.03. The company had revenue of $599.20 million during the quarter, compared to analyst estimates of $601.46 million. Waters had a net margin of 24.09% and a return on equity of 50.64%. Waters’s revenue for the quarter was up .5% on a year-over-year basis. During the same period in the prior year, the business posted $1.95 earnings per share. Research analysts forecast that Waters will post 9.01 earnings per share for the current fiscal year.

Waters Company Profile

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Featured Story: Compound Interest and Why It Matters When Investing

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.